Mohamed Bekradda
AuthID: R-00J-P33
1
TITLE: Clinical activity of MCLA-128 (zenocutuzumab) in combination with endocrine therapy (ET) in ER+/HER2-low, non-amplified metastatic breast cancer (MBC) patients (pts) with ET-resistant disease who had progressed on a CDK4/6 inhibitor (CDK4/6i).
AUTHORS: Barbara Pistilli; Hans Wildiers; Erika Paige Hamilton; Ana Alexandra Ferreira; Florence Dalenc; Maria Vidal; Joaquin Gavila; Anthony Goncalves; Carmen Murias; Marie Ange Mouret Reynier; Jean Luc Re Canon; Fernando Bazan; Sylvain Ladoire; Andres A Sirulnik; Mohamed Bekradda; Kees Bol; Viktoriya Stalbovskaya; Anastasia Murat; Jim Ford; Francois Clement Bidard;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 15
AUTHORS: Barbara Pistilli; Hans Wildiers; Erika Paige Hamilton; Ana Alexandra Ferreira; Florence Dalenc; Maria Vidal; Joaquin Gavila; Anthony Goncalves; Carmen Murias; Marie Ange Mouret Reynier; Jean Luc Re Canon; Fernando Bazan; Sylvain Ladoire; Andres A Sirulnik; Mohamed Bekradda; Kees Bol; Viktoriya Stalbovskaya; Anastasia Murat; Jim Ford; Francois Clement Bidard;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 15
INDEXED IN: 
WOS
WOS